Financial News
Natera Inc (NQ: NTRA )
118.26
+2.01
(+1.73%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
All News about Natera Inc
![](https://cdn.benzinga.com/files/images/story/2024/03/12/disney_plus.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20240312178257/en/1736351/22/Natera_floret_Logo_%281%29.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/options_image_0.jpeg?width=1200&height=800&fit=crop)
9 Health Care Stocks Whale Activity In Today's Session
March 08, 2024
Via Benzinga
![](https://mms.businesswire.com/media/20240307491560/en/1736351/22/Natera_floret_Logo_%281%29.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
Recap: Natera Q4 Earnings
February 28, 2024
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2017/05/IRU33.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/Wall-Street-bull_2.png?width=1200&height=800&fit=crop)
Wall Street Takes A Breather As Inflation Stays Tamed, AMD Hits Record Highs, Apple Struggles: What's Driving Markets Thursday?
February 29, 2024
Via Benzinga
Topics
Economy
Exposures
Interest Rates
![](https://mms.businesswire.com/media/20240229781750/en/1736351/22/Natera_floret_Logo_%281%29.jpg)
Natera to Participate in March Investor Conferences
February 29, 2024
From Natera, Inc.
Via Business Wire
![](/next-assets/images/schema-image-default.png)
Earnings Preview For Natera
February 27, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
A Glimpse Into The Expert Outlook On Natera Through 9 Analysts
February 20, 2024
Via Benzinga
![](https://www.chartmill.com/images/uploads/CM_Breakout_Stocks_Small_free_bb09e243c7.jpeg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 28, 2024
Via Benzinga
![](https://mms.businesswire.com/media/20240228987949/en/1736351/22/Natera_floret_Logo_%281%29.jpg)
Natera Reports Fourth Quarter and Full Year 2023 Financial Results
February 28, 2024
From Natera, Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2024/Cathie-Wood_4.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20240227183728/en/1736351/22/Natera_floret_Logo_%281%29.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20240226912876/en/1736351/22/Natera_floret_Logo_%281%29.jpg)
![](https://mms.businesswire.com/media/20240220780446/en/1736351/22/Natera_floret_Logo_%281%29.jpg)
Natera Announces Fourth Quarter and Fiscal 2023 Earnings Conference Call
February 20, 2024
From Natera, Inc.
Via Business Wire
![](https://investorplace.com/wp-content/uploads/2022/06/biotechnologyepzm1600.png)
![](https://investorplace.com/wp-content/uploads/2024/02/nvta1600-2.png)
![](https://cdn.benzinga.com/files/images/story/2024/Gene-therapy-30281390100-418857d210-o.jpeg?width=1200&height=800&fit=crop)
SoftBank-Backed Genetic Testing Invitae's Descent from $7B Valuation to Near-Bankruptcy
February 05, 2024
Via Benzinga
Topics
Bankruptcy
![](https://cdn.benzinga.com/files/images/story/2024/02/05/pinterest-logo.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20240205986663/en/1736351/22/Natera_floret_Logo_%281%29.jpg)
New Study Validates Signatera™ in Endometrial Cancer
February 05, 2024
From Natera, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20240130015768/en/1736351/22/Natera_floret_Logo_%281%29.jpg)
![](https://www.financialnewsmedia.com/wp-content/uploads/2021/06/FNM-GA-Logo1-1.jpg)
![](https://mms.businesswire.com/media/20240129057731/en/1736351/22/Natera_floret_Logo_%281%29.jpg)
![](https://ml.globenewswire.com/media/9c3ffae4-603d-404f-93cf-1106337e9e0b/small/finacialnews-logo-final-01-2-png.png)
From FN Media Group LLC
Via GlobeNewswire
![](https://mms.businesswire.com/media/20240125943032/en/1736351/22/Natera_floret_Logo_%281%29.jpg)
![](https://mms.businesswire.com/media/20240121559590/en/1736351/22/Natera_floret_Logo_%281%29.jpg)
Natera Acquires Reproductive Health Assets from Invitae
January 22, 2024
From Natera, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.